- Home
- WALD vs SIGA Comparison
WALD vs SIGA Comparison
Compare WALD & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WALD
- SIGA
- Stock Information
- Founded
- WALD 1988
- SIGA 1995
- Country
- WALD United Kingdom
- SIGA United States
- Employees
- WALD N/A
- SIGA N/A
- Industry
- WALD Package Goods/Cosmetics
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- WALD Consumer Discretionary
- SIGA Health Care
- Exchange
- WALD Nasdaq
- SIGA Nasdaq
- Market Cap
- WALD 404.2M
- SIGA 443.4M
- IPO Year
- WALD 2021
- SIGA 1997
- Fundamental
- Price
- WALD $3.03
- SIGA $6.32
- Analyst Decision
- WALD Strong Buy
- SIGA
- Analyst Count
- WALD 4
- SIGA 0
- Target Price
- WALD $5.95
- SIGA N/A
- AVG Volume (30 Days)
- WALD 82.7K
- SIGA 422.2K
- Earning Date
- WALD 08-27-2024
- SIGA 03-11-2025
- Dividend Yield
- WALD N/A
- SIGA 9.53%
- EPS Growth
- WALD N/A
- SIGA N/A
- EPS
- WALD N/A
- SIGA 1.20
- Revenue
- WALD $240,382,000.00
- SIGA $173,731,386.00
- Revenue This Year
- WALD $27.29
- SIGA $16.79
- Revenue Next Year
- WALD $19.54
- SIGA $15.08
- P/E Ratio
- WALD N/A
- SIGA $5.30
- Revenue Growth
- WALD N/A
- SIGA 399.31
- 52 Week Low
- WALD $2.41
- SIGA $4.26
- 52 Week High
- WALD $9.46
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- WALD 37.47
- SIGA 51.04
- Support Level
- WALD $2.96
- SIGA $6.16
- Resistance Level
- WALD $3.15
- SIGA $6.58
- Average True Range (ATR)
- WALD 0.21
- SIGA 0.26
- MACD
- WALD -0.06
- SIGA 0.04
- Stochastic Oscillator
- WALD 23.57
- SIGA 68.67
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. It is organized into two reportable segments namely Obagi Skincare and Milk Makeup.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.